A J Eerenberg-Belmer

Author

Also Known As

A EERENBERGBELMER, A J Eerenberg-Belmer, A J M Eerenberg-Belmer, A.J.M. Eerenberg-Belmer, AJM Eerenberg-Belmer, Anke Eerenberg-Belmer, Anke J. M. Eerenberg‐Belmer, Aria Yazdanbakhsh

Publications

763

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Dutch Blood Transfusion Society Vrije Universiteit Amsterdam Luzerner Kantonsspital Sanquin

About

A J Eerenberg-Belmer is an author at University of Amsterdam specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	506
2	Immunology	8	8	492
3	Allergy	4	4	198
4	Cell Biology	2	2	95
5	Health Sciences	1	1	60

A J Eerenberg-Belmer

Publications

697

Citations

H-Index

Page 1

	Year	Citations
Proteolytic inactivation of plasma C1- inhibitor in sepsis. Jan H. Nuijens, A J Eerenberg-Belmer, C C Huijbregts, Journal of Clinical Investigation InflammationComplement SystemIntrinsic CoagulationSevere SepsisAutoimmune Disease	1989	141
Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects. L. G. Thijs, C. Erik Hack, R J Strack van Schijndel, The Journal of Immunology Il-2 TherapyImmunologyImmune SystemImmunotherapyIl-2 Infusion	1990	86
A C1-inhibitor-complex assay (INCA): a method to detect C1 activation <i>in vitro</i> and <i>in vivo</i>. C.E. Hack, A.J. Hannema, A J Eerenberg-Belmer, The Journal of Immunology	1981	73
Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction Sacha Zeerleder, C HACK, Christoph Caliezi, Clinical Immunology InflammationSevere SepsisMedicineImmunologyImmune Regulation	2005	64
Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis Sacha Zeerleder, Christoph Caliezi, Gerard van Mierlo, Clinical and Vaccine Immunology	2003	63
Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia Johanna W. Baars, Jan Paul de Boer, John Wagstaff, British Journal of Haematology Il-2 TherapyImmunologyPharmacotherapyIl-2 InfusionInflammation	1992	60
SLE like syndrome and functional deficiency of C1q in members of a large family. A.J. Hannema, Hanneke C. Kluin‐Nelemans, C.E. Hack, PubMed Glomerular DiseaseVasculitisFamily MembersGeneticsRenal Pathology	1984	50
The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant Interleukin-2 C. Erik Hack, John Wagstaff, A J Eerenberg-Belmer, British Journal of Cancer InflammationComplement SystemAllergyGranulocyteImmunology	1992	48
Polyethylene glycol enhances the binding of C1q to circulating immune complexes C.E. Hack, A J Eerenberg-Belmer, A.J. Hannema, Journal of Immunological Methods InflammationAutoimmune DiseaseImmunoengineeringImmunologyImmunologic Mechanism	1981	31
Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis C. Erik Hack, A J Eerenberg-Belmer, Uwi G. Lim, Arthritis & Rheumatism	1984	28

Page 1